Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001866191-21-000001
Filing Date
2021-06-09
Accepted
2021-06-09 17:19:26
Documents
2
Period of Report
2021-06-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 5517
2 poapepose.txt EX-24 2916
  Complete submission text file 0001866191-21-000001.txt   10047
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 37000 GRAND RIVER AVE SUITE 120 FARMINGTON HILLS MI 48335
Business Address
Pepose Jay (Reporting) CIK: 0001866191 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34079 | Film No.: 211006006